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The aim of the paper was to assess success rates and associated maternal and fetal 
risks, to determine the different methods of induction for labor at term, compare 
induction with Foley catheter and induction with naturally  occurring prostaglandin E2 
(PGE2) tablets in women with gestational age at term. 
Two hundred and twelve women at term were included into the study, one group 
with Foley catheter, the second group with PGE2 tablets, with a maximum of two doses. 
The primary  outcome measures were the admission-to-delivery interval and the 
induction-to-delivery interval. Secondary outcomes included cesarean section rate, mode 
of delivery, and maternal and neonatal safety outcome. Results were calculated by 
applying the Fisher’s exact test, c2-test, t-test and calculating the P-value using an 
alpha level of 0.05 for Type I errors. 
The mean time from admission to delivery was 13.53h in the  Foley catheter group 
and 12.30h in the PGE2 group (P=0.090). The induction-to-delivery interval was also 
comparable between the groups (10.75h vs 9.37h), while the cesarean section rate did 
not differ significantly between them (7.61% vs 15.30%). More women in the 
misoprostol group had an instrumental delivery (12.38% vs 2.94%). The only significant 
difference in neonatal outcome was a larger number of babies born with Apgar score < 7 
at 1 min in the Foley group. Maternal outcomes were not significantly different, except 
for a higher number of digital examinations in the Foley group. 
Foley catheter is equally efficacious in labor induction and demonstrates a similar 
fetal and maternal safety profile to PGE2. Acta Medica Medianae 2013;52(4):21-26. 
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Introduction 
 
  Induction of labor refers to the iatrogenic 
stimulation of uterine contractions before the 
onset of spontaneous labor to accomplish vaginal 
delivery. It is a commonly performed procedure 
in obstetrics, with an incidence ranging from 5 to 
30 % of all pregnancies (1). It is performed when 
the perceived benefits of delivery outweighs the 
risks associated with labor induction. 
In the late nineties, the rate of induction of 
labor was 19% in the US (2), 23% in Australia 
(3), and 21% in the UK (4). In the UK, the rate 
of cesarean delivery nearly tripled during the 
1970s and the 1980s (5), and in 2000, 22% of 
pregnant women were delivered by cesarean (4). 
In the US, cesarean delivery rates increased from 
17% in 1980 to 24% in 1990 (6), and this trend 
continues presently (7). 
The major concern over labor induction is a 
failure to achieve vaginal delivery, when emer-
gency cesarean section becomes the only option. 
The risk of emergency cesarean section in women 
undergoing labor induction has been reported to be 
25% for nulliparous and 6% for multiparous 
women (8). However, the effects of labor induction 
on childbirth, in general, are still the subject of 
considerable controversy (9). According to different 
publications, inducing labor has been found to 
both increase and decrease the risk of cesarean 
delivery (3,10,11). 
The decision to induce labor in less imminent 
situations is often difficult. If the induction fails, an 
emergency cesarean delivery will be indicated. It is 
well established that maternal risks are greater in 
emergency cesareans when compared to vaginal 
deliveries or to elective cesarean deliveries (12). 
Often a decision to induced labor is made, because 
vaginal delivery is considered safer and more 
beneficial than an elective cesarean  delivery for 
both mother and child (13). This risk, however, is 
related to various factors, including the indications 
for induction, the cervical status and the methods Comparison of Foley catheter and prostaglandin E2 tablets...                                                                Ana Daneva Markova et al. 
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used. However, the recurring dilemma is that if 
the induction is unsuccessful, the intention to 
accomplish a safe beneficial delivery is not 
realized. 
Identifying those pregnancies that can be 
induced with low failure risk should be of utmost 
importance. Previous studies have found that null 
parity and a low Bishop score increase the rate of 
failed induction and of a cesarean delivery (10, 
11). However, our knowledge of factors influen-
cing the risk of emergency cesarean delivery in 
women undergoing labor induction is still limited. 
Moreover, there is no available data on this topic 
in the Republic of Macedonia.  
In this study, we evaluated the different 
indications for labor induction, the different 
methods used and success rates associated with 
maternal and fetal risks. 
Our study hypothesis was that immediate 
induction with Foley catheter will result in a 
significant shortening of the induction-to-delivery 
time in compression to immediate induction with 
vaginal PGE2 tablet. 
We evaluated, retrospectively, all labor in-
ductions  which occurred in the past two years 
(2010-2012) at the University Clinic of Obstetrics 
and Gynecology, Skopje. Our center is the largest 
birth center in the country, and the only tertiary, 
university affiliated center in the country. 
 
Materials and Methods 
 
Study design 
 
This is a retrospective database study. Data 
related to all labor inductions from January 2010 
to January 2012 was analyzed. Our center is the 
largest birth center in the country, and the only 
tertiary, university affiliated center in the country.  
We included in our analysis all deliveries 
requiring labor induction during the time period 
mentioned above. Mothers with multiple pregnan-
cies, previous cesarean section, no cephalic 
presentation at birth, stillbirths and preterm 
deliveries (less than 37 completed weeks of 
gestation) are excluded. Women were excluded 
from the study if they were in labor (the onset of 
labor was defined as regular contractions 
occurring twice in 10 min by non-stress test, or if 
there was a contraindication to the induction of 
labor  (such as placenta previa or meconium 
staining of the amniotic fluid).  
 
Treatment schedule 
 
On admission to the delivery room complex 
if the inclusion criteria were met, informed 
consent for inclusion in the study was requested 
by the medical staff and no woman refused it. At 
the time of diagnosis, Bishop’s scoring was also 
done, uterine contractions and fetal heart rate 
were monitored using electronic fetal monitoring 
for 1h. If the fetal heart rate was normal and if 
contractions were not present, the woman was 
randomly allotted to either the group undergoing 
immediate induction with Foley catheter (Group 1) 
or that undergoing immediate induction with 
PGE2 tablets (Group 2). 
Women assigned to Group 1 were treated 
with a Foley catheter in the cervical channel 
instilled with 70ml NACL 0, 9%. Women in Group 
2 were given 0.5mg PGE2 tablets instilled in the 
posterior vaginal fornix every 6h, for up to a 
maximum of two doses. The medications were 
administered by the trainee residents and 
application of the inducing agents was stopped if 
the woman was found to be in the active phase 
of labor (cervical dilatation  3cm and uterine 
contractions 3/10min). If the contractions subse-
quently became inadequate, an oxytocin infusion 
was used to augment labor so that three 
contractions were obtained in 10min or  a 
maximum dose of oxytocin (32mIU/min) was 
achieved. The women were carefully monitored 
every half an hour for side effects and the onset 
and progress of labor. Vaginal examination was 
performed every 4h to assess the progress of 
labor. Abnormal labor was defined very specifically. 
Failure to progress in the latent phase was 
defined as a period of 24h in primigravidas and 
14h in multigravidas without progress. Failure to 
progress in the active phase of labor was defined 
as failure of further cervical dilatation after 3cm 
dilatation or failure of descent of the presenting 
part after 2h of adequate uterine contractions. 
Failure to progress in the second stage of labor 
was defined as the absence of further descent of 
the presenting part over a period of 2h in 
primigravidas and 1h in multigravidas in spite of 
adequate uterine activity. At delivery the Apgar 
scores were determined. Babies in both groups 
had a blood sample taken for white cell counts 
and culture within 24h of birth and before 
treatment with antibiotics. Other tests and 
treatment given to the babies were determined 
by visiting pediatricians. 
 
Outcome measures 
 
Our primary outcome measures were the 
induction to-delivery and admission-to-delivery 
intervals. Secondary outcome measures were the 
caesarean section rate, maternal morbidity, 
neonatal morbidity and mortality. The fetal heart 
rate was monitored by using electronic fetal 
monitoring during 1h of observation and for the 
first 2h after the administration of inducing 
agents. Intermittent auscultation was performed 
every hour before the onset of labor and every 
half an hour during labor. If the fetal heart rate 
was abnormal during intermittent auscultation, 
continuous electronic fetal monitoring was 
performed throughout labor. The changes in fetal 
heart rate that were considered abnormal 
included persistent decelerations (early, late, or 
variable decelerations), fetal tachycardia (fetal Acta Medica Medianae 2013, Vol.52(4)                                              Comparison of Foley catheter and prostaglandin E2 tablets... 
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heart rate >160beats/min), fetal bradycardia (fetal 
heart rate <100beats/min), or reduced short term 
variability (<5beats/min). Failure of induction was 
defined as no onset of labor after 24h following 
the initiation of induction of labor. Tachysystole 
was defined as at least six contractions in 10min. 
Hyperstimulation was defined as the presence of 
tachysystole associated with fetal tachycardia, 
late decelerations, or loss of beat-to-beat variability. 
Recognized episodes of hyper stimulation were 
managed with a change in the maternal position, 
oxygen administration. Hyper tonus was defined 
as a uterine contraction lasting at least 2min. The 
occurrence of chorioamnionitis (maternal fever 
usually associated with maternal and fetal tachy-
cardia, uterine tenderness and peripheral leuko-
cytosis) and postpartum endometritis (the presence 
of maternal fever and uterine tenderness, leuko-
cytosis and foul-smelling lochia) was evaluated in 
all patients. Sepsis in the neonate was defined as 
at least one positive blood culture believed not to 
be a contaminant. The physicians who managed 
labor were not blinded to the study group allocation. 
 
Statistical analysis 
 
All data were collected in a preform prepared 
for the study. The data were analyzed with Epi info 
software and Microsoft Excel software (Redmond, 
WA, USA). Analyses were done using the modified 
intention to treat principle. The modified intention 
to treatment population comprised all women 
who were randomized to treatment and received 
at least one proper dose of study drug. We did 
not have a prespecified stopping rule based on 
superiority of regimen before the trial ended. 
Results were calculated applying Fisher’s exact 
test, the c2-test and the t-test, and calculating 
the P-value using an alpha level of 0.05 for Type 
I errors. 
 
Results  
 
Of the 264 women eligible for admission 
into the study, 52 women were not included 
because of various reasons (gestational age <37 
weeks, fetal distress, meconium-stained amniotic 
fluid, breech and compound presentation, and 
contractions started during observation). Following 
randomization, 110 women were included in the 
Foley group and 102 women in the PGE2 tablet 
group. Of 110 women in the Foley group, four 
had improper administration of Foley catheter 
and one refused the treatment with Foley catheter; 
they were excluded from the final analysis. 
 
Primary outcome 
 
Results for the primary outcome variable 
are presented in Table 2. As can be seen, there 
were no significant differences between the two 
treatments groups for the time interval from 
induction to the onset of labor, induction-to-
delivery interval, time in hospital before delivery, 
however, women in Group II had a shorter 
duration of active labor. 
 
Secondary outcome 
 
Secondary outcome measures are shown in 
Tables 4 and 5. The rate of cesarean section did 
not differ significantly between groups (Table 4), 
but the operative vaginal delivery rate was 
significantly higher in Group I among nulliparous 
women (13% vs 3%, P=0.022). In Group I, three 
cesarean sections had to be carried out for failure 
of induction and five women had secondary 
arrest of labor in the active phase. In Group II, 
three women had failure of induction; six had 
fetal distress and six had secondary arrest of 
labor in the active phase. 
Table 1. Baseline characteristics at the entry into the trial 
 
Characteristics  Immediate induction 
with PGE2 gel (n = 102) 
Immediate induction 
with Foley catheter(n = 110) 
value 
Maternal age (years) †  23.02±3.59  23.09±3.54  0.444* 
Gestational age (weeks) †  38.40±0.85  38.26±0.87  0.119* 
Parity 
0  87  81  0.954** 
≥1  23  21  0.954** 
Ultrasound needed to confirm 
gestational age 
85  90  0.035** 
Interval from rupture of 
membranes to admission (hours) †  4.22±2.36  4.46±2.66  0.245* 
Methods of confirming rupture of 
membranes pooling of amniotic 
fluid on speculum examination 
103  96  0.883** 
Absence of membranes on digital 
examination 
95  91  0.527** 
Reduced liquor volume (AFI < 5) 
on ultra sonography 
24  21  0.826** 
Bishop 
score 
≥6  38  42  0.319** 
<6  72  60  0.319** 
* Using the t-test, ** Using the c2-test, † Values are mean _ SD,  
AFI - amniotic fluid index, PGE2 - prostaglandin E2 Comparison of Foley catheter and prostaglandin E2 tablets...                                                                Ana Daneva Markova et al. 
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Table 2. Timing of events after induction 
 
  Immediate induction 
with Foley (N=105 
Immediate induction 
with PGE2 gel (n = 102)  P value 
Time to active labor†‡  5.36±4.54  4.59±3.87  0.123 
Duration of active labor†‡  4.73±2.73  2.82±1.47  <0.001 
Induction-to-delivery interval  10.75±6.69  9.37±5.48  0.0526 
Time in hospital before delivery  13.53±7.45  12.30±5.55  0.090 
Interval from membranes rupture to 
delivery  16.97±6.94  16.77±6.06  0.413 
Values are mean _ SD, * Using the t-test, † Three women in the Foley group who had induction failure and did not 
go into labor were excluded from the analysis 
‡ Six women in the prostaglandin E2 (PGE2) group who had induction failure and six women who had fetal distress 
before the onset of active labor were excluded from the analysis 
 
Table 3. Mode of delivery 
 
  Immediate induction with 
Foley (N=105) 
Immediate induction 
with PGE2 gel (n = 102)  P value 
Nulliparous 
Cesarean section  08 (9.52%, 8/84)  15 (18.51%, 15/81)  0.105** 
Operative vaginal 
delivery  13 (15.47%, 13/84)  03 (3.70%, 3/81)    0.011*** 
Spontaneous 
vaginal delivery  63 (75.00%, 63/84)  63 (77.77%, 63/81)      0.794 
Total  84 (100%)  81 (100%)   
Multiparous 
Cesarean section  0  0  - 
Operative vaginal 
delivery  0  0  - 
Spontaneous 
vaginal delivery  21 (100%, 21/21)  21 (100%, 21/21)  0.916 
Total  21 (100%)  21 (100%)   
* Using the c2-test with Yates correction done where necessary, PGE2 - prostaglandin E2 
** P = 0.095 when calculated in nulliparous women only, *** P = 0.011 when calculated in nulliparous women only 
 
Table 4. Maternal outcome 
 
Outcome measurement  Immediate induction 
with Foley (N=105) 
immediate induction 
with PGE2 gel (n = 102)  P value 
Clinical chorioamnionitis  0  0   
Analgesic use  63 (60%, 63/105)  52 (50.98%, 52/102)  0.191* 
Abnormal fetal heart rate  03 (2.85%, 3/105)  06 (05.88%, 6/102)    0.644 ** 
Hypertonus  0  03 (2.85%, 3/105)   
Antibiotic used 
Penicillin  52 (49.52%, 52/105)  58 (56.86%, 58/102)  0.290* 
Cephalosporin  53 (50.47%, 53/105)  44 (43.13%, 44/102)  0.290* 
Number of 
vaginal digital 
examination 
<4  53 (50.47%, 53/105)  76 (74.50%, 76/102)  0.0003* 
4–8  52 (49.52%, 52/105)  26 (25.49%, 26/102)   0.0003* 
Post partum fever  01 (0.95%, 1/105)  01 (0.98%, 1/102)    0.743** 
* Using the c2-test. ** Fisher’s exact test one-tailed value,  
† None of the women in either group vomited or had hyperstimulation, tachysystole or post partum hemorrhage, 
PGE2 - prostaglandin E2 
 
Table 5. Neonatal outcome 
 
Neonatal outcome  Immediate induction 
with Foley (N=105) 
immediate induction 
with PGE2 gel (n = 102)  P value 
Apgar score 
<7 at 1 min  12 (11.42%, 12/105)  03 (2.94%, 3/102)  0.036* 
<7 at 5 min  01 (0.95%, 1/105)  01 (0.09%, 1/102)  0.743** 
Ventilation after initial resuscitation  08 (7.61%, 8/105)  03 (2.94%, 3/102)  0.233* 
Stay in intensive neonatal care unit  12 (11.42%, 12/105)  09 (8.82%, 9/102)  0.534* 
Neonatal antibiotics  08 (7.61%, 8/105)  06 (5.88%, 6/102)  0.618* 
Neonatal infection  03 (2.85%, 3/105)  03 (2.94%, 3/102)  0.644** 
Neonatal seizure  01 (0.95%, 1/105)  01 (0.09%, 1/102  0.743** 
Neonatal death  01 (0.95%,1/105)  01 (0.92%, 1/102)  0.743** 
* Using the c2-test with Yates correction done whenever necessary, ** Fisher’s exact test one-tailed value Acta Medica Medianae 2013, Vol.52(4)                                              Comparison of Foley catheter and prostaglandin E2 tablets... 
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We also examined the rate of cesarean 
section in the two groups considering Bishop’s 
score at the time of randomizing to study groups. 
At randomization, in Group I there were 69 
women (three women had been excluded) who 
had a Bishop score <6, and in them the rate of 
cesarean section was 4.3% (3/69). In Group II 
there were 60 women with a Bishop score <6 and 
the rate of cesarean section was 15% (9/60) 
(P=0.076). Maternal outcome in regard to clinical 
chorioamnionitis, analgesic use and postpartum 
fever were similar in both groups (Table 5), but 
the number of digital vaginal examinations was 
significantly higher in Group I than Group II 
(P=0.0003). Blood samples were taken for a 
white cell count and culture in more than 80% of 
babies in the two groups. The rate of neonatal 
infection did not differ between the groups (Table 
6). A higher number of babies born in Group I 
had a low Apgar score at 1min, but this 
difference did not exist at 5min. One baby in 
Group II had a delivery with an Apgar score 4/6 
at 38 weeks’ gestation. The baby died 48h after 
birth and the cause of death was asphyxia. In 
Group II also one baby was delivered 
asphyxiated with Apgar scores of 3/4 and the 
baby died six days after delivery. 
 
Discussion 
 
There are many studies that have com-
pared either intravaginal application of Foley 
catheter or PGE2 tablets for induction of labor at 
and near term and found to be of benefit 
(5,6,12,13). Until now, Foley catheter has not 
been tested against PGE2 in a study designed 
exclusively for patients at term. Our study shows 
that Foley catheter was not associated with 
significant differences in time in hospital before 
delivery, induction delivery interval, caesarean 
section rate, or maternal and neonatal infectious 
morbidity when compared with vaginal PGE2 
tablets. Foley catheter was associated with an 
increased need for operative vaginal delivery, a 
larger number of digital vaginal examinations and 
a larger number of babies born with an Apgar 
score <7 at 1min. Several investigators have 
compared immediate induction with Foley 
catheter with immediate or delayed induction 
with oxytocin in women with PROM at term 
(12,13,15). These studies have shown Foley 
catheter to have equal efficacy and similar 
adverse effects to immediate induction with 
oxytocin (12,13) or to be more effective than 
expected treatment followed by oxytocin (15). 
The mean induction-to-delivery time of the Foley 
catheter group in our study and other secondary 
outcomes, such as caesarean section rate, and 
maternal and perinatal outcome, are in 
agreement with the Foley catheter group of these 
studies. 
 Several studies have been conducted that 
have compared 25mg vaginal misoprostol with 
PGE2 preparations (0.5 mg, 16 2mg, 17 3 mg18) 
for induction of labor in women without PROM 
and have found misoprostol to be equally 
effective (17) or more effective than PGE2 with 
similar maternal and neonatal outcomes (16). 
Our trial has compared immediate induction with 
Foley catheter to PGE2 tablets for induction of 
labor at term. The findings do not support the 
study hypothesis that Foley catheter results in a 
shorter time interval from induction to delivery 
than PGE2 tablets. Our study was not blinded 
because it was not financially or technically 
feasible. Neonatal caregivers were not masked to 
subject allocation, but bias would be unlikely to 
influence neonatal treatment decisions. Our 
primary outcome, the time interval to delivery, 
was  unlikely to be influenced as the attending 
physicians at each birth had no vested interest in 
the study conclusion. In conclusion, our study 
was unable to demonstrate any advantage for 
Foley catheter over PGE2 tablets with regard to 
the induction-to-delivery interval and mode of 
delivery. Our findings support the relative safety 
of Foley catheter compared to PGE2 tablets. 
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UPOREĐIVANJE FOLEY KATETERA I PROSTAGLANDIN E2 TABLETA 
KOD INDUKOVANOG POROĐAJA U TERMINU 
 
Ana Daneva Markova, Marija Hadži-Lega, Milan Stefanović 
 
 
Cilj ispitivanja bio je procena stope uspeha i rizika po majku i fetus,  kao i 
utvrđivanje  različitih  metoda  indukcija  porođaja  u  terminu  i  upoređivanje  indukcije 
pomoću Foley katetera i indukcije tabletama prostaglandina E2 (PGE2).  
Ispitivanje je obuhvatalo 212 žena koje su se porodile u terminu, pri čemu su prvu 
grupu činile žene kod kojih je porođaj indukovan Foley kateterom, a drugu grupu žene 
kod kojih je porođaj indukovan PGE2 tabletama sa maksimalno dve doze. Primarne mere 
uspeha  bile  su  period od  trenutka  prijema  do  trenutka  porođaja  i  period  od  trenutka 
indukcije  do  trenutka  porođaja.  U  sekundarne  mere  uspeha spadali su stopa carskog 
reza, način porođaja i bezbednost majke i novorođenčeta. Rezultati su dobijeni izraču-
navanjem i pomoću Fišerovog egzaktnog testa, c2-testa, t-testa kao i izračunavanjem P-
vrednosti na alfa nivou od 0.05 za greške tipa I.  
Srednje vreme od trenutka prijema do trenutka porođaja iznosilo je 13.53 h u grupi 
sa Foley kateterom i 12.30 h grupi sa PGE2 (P=0.090). Vršeno je  upoređivanje  od 
trenutka indukcije do trenutka porođaja (10.75 h vs 9.37 h), s tim što se stopa carskog 
reza nije značajno razlikovala između prve dve grupe (7.61% vs 15.30%). Većina žena u 
grupi  sa  mizoprostolom  imala  je  instrumentalni  porođaj  (12.38%  vs  2.94%). Jedina 
značajna razlika odnosila se na veći broj beba rođenih sa Apgar skorom <7 u 1 min u 
grupi sa Foley kateterom. Stopa uspeha porođaja kod majki nije se značajno razlikovala, 
osim što je veći broj pregleda prstima bio izvršen u grupi sa Foley kateterom.  
Foley  kateter  je  podjednako efikasan  kod  indukovanog  porođaja  i  pokazuje  slični 
profil bezbednosti za majku i fetus kao i PGE2. Acta Medica Medianae 2013;52(4):21-26. 
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